EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study

Guomei Xia, Shanshan Sun, Shijun Zhou, Lei Li, Xu Li, Guizhou Zou, Cheng Huang, Jun Li, Zhenhua Zhang iD

PLOS Neglected Tropical Diseases · 2023

DOI: 10.1371/journal.pntd.0011158 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift PLOS Neglected Tropical Diseases, 2023. Verfasst von Guomei Xia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Virology, Department of Infectious Diseases, The Second Hospital of Anhui Medical University, Hefei, China. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Phlebovirus, Thrombocytopenia. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University Natural Science Research Project of Anhui Province, Scientific research project of Anhui Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background There are a few models for predicting the outcomes of patients with severe fever with thrombocytopenia syndrome (SFTS) based on single-center data, but clinicians need more reliable models based on multicenter data to predict the clinical outcomes and effectiveness of drug therapy. Methodology/Principal findings This retrospective multicenter study analyzed data from 377 patients with SFTS, including a modeling group and a validation group. In the modeling group, the presence of neurologic symptoms was a strong predictor of mortality (odds ratio: 168). Based on neurologic symptoms and the joint indices score, which included age, gastrointestinal bleeding, and the SFTS virus viral load, patients were divided into double-positive, single-positive, and double-negative groups, which had mortality rates of 79.3%, 6.8%, and 0%, respectively. Validation using data on 216 cases from two other hospitals yielded similar results. A subgroup analysis revealed that ribavirin had a significant effect on mortality in the single-positive group (P = 0.006), but not in the double-positive or double-negative group. In the single-positive group, prompt antibiotic use was associated with reduced mortality (7.2% vs 47.4%, P < 0.001), even in individuals without significant granulocytopenia and infection, and early prophylaxis was associated with reduced mortality (9.0% vs. 22.8%, P = 0.008). The infected group included SFTS patients with pneumonia or sepsis, while the noninfected group included patients with no signs of infection. The white blood cell count and levels of C-reactive protein and procalcitonin differed significantly between the infection and non-infection groups (P = 0.020, P = 0.011, and P = 0.003, respectively), although the absolute difference in the medians were small. Conclusions/Significance We developed a simple model to predict mortality in patients with SFTS. Our model may help to evaluate the effectiveness of drugs in these patients. In patients with severe SFTS, ribavirin and antibiotics may reduce mortality.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Severe Fever with Thrombocytopenia SyndromePhlebovirusThrombocytopeniaHumansRibavirinRetrospective StudiesC-Reactive Protein

Substanzen

RibavirinC-Reactive Protein

Autor:innen und Institutionen

  • Institute of Clinical Virology, Department of Infectious Diseases, The Second Hospital of Anhui Medical University, Hefei, China.
  • Department of Infectious Diseases, Anhui Provincial Hospital of Anhui Medical University, Hefei, China.
  • Department of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, China.
  • Inflammation and Immune Mediated Diseases Laboratory of Anhui Province, Anhui Institute of Innovative Drugs, School of Pharmacy, Anhui Medical University, Hefei, China.

ORCID-Profile: Zhenhua Zhang

Förderung

  • University Natural Science Research Project of Anhui Province
  • Scientific research project of Anhui Medical University

Zitieren

APA

Xia, G., Sun, S., Zhou, S., Li, L., Li, X., Zou, G., Huang, C., Li, J., & Zhang, Z. (2023). A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study. PLOS Neglected Tropical Diseases. https://doi.org/10.1371/journal.pntd.0011158

Vancouver

Xia G, Sun S, Zhou S, Li L, Li X, Zou G, et al. A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study. PLOS Neglected Tropical Diseases. 2023. doi:10.1371/journal.pntd.0011158

BibTeX
@article{Xia2023,
  author = {Xia, Guomei and Sun, Shanshan and Zhou, Shijun and Li, Lei and Li, Xu and Zou, Guizhou and Huang, Cheng and Li, Jun and Zhang, Zhenhua},
  title = {A new model for predicting the outcome and effectiveness of drug therapy in patients with severe fever with thrombocytopenia syndrome: A multicenter Chinese study},
  journal = {PLOS Neglected Tropical Diseases},
  year = {2023},
  doi = {10.1371/journal.pntd.0011158}
}
Kostenlos starten →